Progression of diabetes, heart disease, and stroke multimorbidity in middle-aged women: A 20-year cohort study
Using data from the Australian Longitudinal Study on Women’s Health, Xiaolin Xu and colleagues examine the progression of diabetes, heart disease, and stroke co- and multimorbidity in middle-aged women over 20 years.
Vyšlo v časopise:
Progression of diabetes, heart disease, and stroke multimorbidity in middle-aged women: A 20-year cohort study. PLoS Med 15(3): e32767. doi:10.1371/journal.pmed.1002516
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pmed.1002516
Souhrn
Using data from the Australian Longitudinal Study on Women’s Health, Xiaolin Xu and colleagues examine the progression of diabetes, heart disease, and stroke co- and multimorbidity in middle-aged women over 20 years.
Zdroje
1. Jackson CA, Dobson AJ, Tooth LR, Mishra GD. Lifestyle and socioeconomic determinants of multimorbidity patterns among mid-aged women: a longitudinal study. PLoS ONE. 2016;11(6). doi: 10.1371/journal.pone.0156804 27258649.
2. Dunlay SM, Chamberlain AM. Multimorbidity in older patients with cardiovascular disease. Curr Cardiovasc Risk Rep. 2016;10. doi: 10.1007/s12170-016-0491-8 27274775.
3. SL R., Wei MY, Kim M, Narayan KMV, Saydah SS. Multimorbidity of four cardiometabolic and chronic pulmonary disease groups: prevalence and attributable fraction in US adults, 2007–2012. J Comorbidity. 2017;7(1):11. doi: 10.15256/joc.2017.7.89 29090186.
4. Emerging Risk Factors Collaboration, Di Angelantonio E, Kaptoge S, Wormser D, Willeit P, Butterworth AS, et al. Association of cardiometabolic multimorbidity with mortality. JAMA. 2015;314(1):52–60. doi: 10.1001/jama.2015.7008 26151266.
5. Lyall DM, Celis-Morales CA, Anderson J, Gill JMR, Mackay DF, McIntosh AM, et al. Associations between single and multiple cardiometabolic diseases and cognitive abilities in 474 129 UK Biobank participants. Eur Heart J. 2017;38(8):577–83. doi: 10.1093/eurheartj/ehw528 28363219.
6. Martín-Timón I, Sevillano-Collantes C, Segura-Galindo A, del Cañizo-Gómez FJ. Type 2 diabetes and cardiovascular disease: have all risk factors the same strength? World J Diabetes. 2014;5(4):444. doi: 10.4239/wjd.v5.i4.444 25126392.
7. Sattar N, McConnachie A, Shaper AG, Blauw GJ, Buckley BM, de Craen AJ, et al. Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies. Lancet. 2008;371(9628):1927–35. doi: 10.1016/S0140-6736(08)60602-9 18501419.
8. Huxley R, Barzi F, Woodward M. Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies. BMJ. 2006;332(7533):73–8. doi: 10.1136/bmj.38678.389583.7C 16371403.
9. Peters SAE, Huxley RR, Woodward M. Diabetes as a risk factor for stroke in women compared with men: a systematic review and meta-analysis of 64 cohorts, including 775 385 individuals and 12 539 strokes. Lancet. 2014;383(9933):1973–80. doi: 10.1016/S0140-6736(14)60040-4 24613026.
10. Mozaffarian D, Marfisi R, Levantesi G, Silletta MG, Tavazzi L, Tognoni G, et al. Incidence of new-onset diabetes and impaired fasting glucose in patients with recent myocardial infarction and the effect of clinical and lifestyle risk factors. Lancet. 2007;370(9588):667–75. Epub 2007/08/28. doi: 10.1016/S0140-6736(07)61343-9 17720018.
11. Kivimaki M, Kuosma E, Ferrie JE, Luukkonen R, Nyberg ST, Alfredsson L, et al. Overweight, obesity, and risk of cardiometabolic multimorbidity: pooled analysis of individual-level data for 120 813 adults from 16 cohort studies from the USA and Europe. Lancet Public Health. 2017;2(6):e277–e85. doi: 10.1016/S2468-2667(17)30074-9 28626830.
12. Rawshani A, Rawshani A, Franzen S, Eliasson B, Svensson AM, Miftaraj M, et al. Mortality and cardiovascular disease in type 1 and type 2 diabetes. N Engl J Med. 2017;376(15):1407–18. Epub 2017/04/14. doi: 10.1056/NEJMoa1608664 28402770.
13. Cholesterol Treatment Trialists Collaborators, Kearney PM, Blackwell L, Collins R, Keech A, Simes J, et al. Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis. Lancet. 2008;371(9607):117–25. doi: 10.1016/S0140-6736(08)60104-X 18191683.
14. Matuleviciene-Anangen V, Rosengren A, Svensson AM, Pivodic A, Gudbjornsdottir S, Wedel H, et al. Glycaemic control and excess risk of major coronary events in persons with type 1 diabetes. Heart. 2017. doi: 10.1136/heartjnl-2016-311050 28710186.
15. Dobson AJ, Hockey R, Brown WJ, Byles JE, Loxton DJ, McLaughlin D, et al. Cohort profile update: Australian Longitudinal Study on Women's Health. Int J Epidemiol. 2015;44(5):1547-f. doi: 10.1093/ije/dyv110 26130741
16. Lee C, Dobson AJ, Brown WJ, Bryson L, Byles J, Warner-Smith P, et al. Cohort Profile: the Australian Longitudinal Study on Women's Health. Int J Epidemiol. 2005;34(5):987–91. doi: 10.1093/ije/dyi098 15894591.
17. Navin Cristina TJ, Stewart Williams JA, Parkinson L, Sibbritt DW, Byles JE. Identification of diabetes, heart disease, hypertension and stroke in mid- and older-aged women: Comparing self-report and administrative hospital data records. Geriatr Gerontol Int. 2015. doi: 10.1111/ggi.12442 25613080.
18. World Health Organization. Obesity: preventing and managing the global epidemic. Report of a WHO Consultation. Geneva: World Health Organization, 2000 9241208945 Contract No.: 894.
19. Brown WJ, Trost SG, Bauman A, Mummery K, Owen N. Test-retest reliability of four physical activity measures used in population surveys. J Sci Med Sport. 2004;7(2):205–15. doi: 10.1016/S1440-2440(04)80010-0 15362316.
20. Schaan BD, de Figueiredo Neto JA, Moreira LB, Ledur P, Mattos LAP, Magnoni D, et al. Diabetes and cardiovascular events in high-risk patients: Insights from a multicenter registry in a middle-income country. Diabetes Res Clin Pract. 2017;127:275–84. doi: 10.1016/j.diabres.2017.03.021 28412543.
21. Dregan A, Chowienczyk P, Molokhia M. Cardiovascular and type 2 diabetes morbidity and all-cause mortality among diverse chronic inflammatory disorders. Heart. 2017. doi: 10.1136/heartjnl-2017-311214 28601812
22. National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand. Reducing risk in heart disease: an expert guide to clinical practice for secondary prevention of coronary heart disease. Melbourne: National Heart Foundation of Australia, 2012.
23. Jones M, Tett S, Peeters GM, Mishra GD, Dobson A. New-Onset Diabetes After Statin Exposure in Elderly Women: The Australian Longitudinal Study on Women's Health. Drugs Aging. 2017;34(3):203–9. doi: 10.1007/s40266-017-0435-0 28138911.
24. Ettehad D, Emdin CA, Kiran A, Anderson SG, Callender T, Emberson J, et al. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet. 2016;387(10022):957–67. doi: 10.1016/S0140-6736(15)01225-8 26724178.
25. Sowers JR, Epstein M, Frohlich ED. Diabetes, hypertension, and cardiovascular disease: an update. Hypertension. 2001;37(4):1053–9. 11304502.
26. Mannino DM, Thorn D, Swensen A, Holguin F. Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. Eur Respir J. 2008;32(4):962–9. doi: 10.1183/09031936.00012408 18579551.
27. Xu X, Mishra GD, Jones M. Evidence on multimorbidity from definition to intervention: an overview of systematic reviews. Ageing Res Rev. 2017;37:53–68. doi: 10.1016/j.arr.2017.05.003 28511964.
28. Byles J, Hockey R, McLaughlin D, Dobson A, Brown W, Loxton D, et al. Chronic conditions, physical function and health care use: Findings from the Australian Longitudinal Study on Women’s Health. Report prepared for the Australian Government Department of Health. 2015.
29. van Oostrom SH, Gijsen R, Stirbu I, Korevaar JC, Schellevis FG, Picavet HS, et al. Time trends in prevalence of chronic diseases and multimorbidity not only due to aging: data from general practices and health surveys. PLoS ONE. 2016;11(8):e0160264. doi: 10.1371/journal.pone.0160264 27482903.
30. Arnold M, Jiang L, Stefanick ML, Johnson KC, Lane DS, LeBlanc ES, et al. Duration of Adulthood Overweight, Obesity, and Cancer Risk in the Women's Health Initiative: A Longitudinal Study from the United States. PLoS Med. 2016;13(8):e1002081. doi: 10.1371/journal.pmed.1002081 27529652.
31. Australian Bureau of Statistics. National Health Survey: First results, 2014–15. Canberra: 2015 Contract No.: 4364.0.55.001.
32. Stavrou E, Vajdic CM, Loxton D, Pearson SA. The validity of self-reported cancer diagnoses and factors associated with accurate reporting in a cohort of older Australian women. Cancer Epidemiol. 2011;35(6):e75–80. doi: 10.1016/j.canep.2011.02.005 21474409.
33. Okura Y, Urban LH, Mahoney DW, Jacobsen SJ, Rodeheffer RJ. Agreement between self-report questionnaires and medical record data was substantial for diabetes, hypertension, myocardial infarction and stroke but not for heart failure. J Clin Epidemiol. 2004;57(10):1096–103. doi: 10.1016/j.jclinepi.2004.04.005 15528061.
34. Hansen H, Schafer I, Schon G, Riedel-Heller S, Gensichen J, Weyerer S, et al. Agreement between self-reported and general practitioner-reported chronic conditions among multimorbid patients in primary care—results of the MultiCare Cohort Study. Bmc Family Practice. 2014;15. doi: 10.1186/1471-2296-15-39 24580758.
35. Burton NW, Brown W, Dobson A. Accuracy of body mass index estimated from self-reported height and weight in mid-aged Australian women. Aust N Z J Public Health. 2010;34(6):620–3. doi: 10.1111/j.1753-6405.2010.00618.x 21134066.
36. Jackson CA, Mishra GD, Tooth L, Byles J, Dobson A. Moderate agreement between self-reported stroke and hospital-recorded stroke in two cohorts of Australian women: a validation study. BMC Med Res Methodol. 2015;15:7. doi: 10.1186/1471-2288-15-7 25613556.
37. Parkinson L, Curryer C, Gibberd A, Cunich M, Byles JE. Good agreement between self-report and centralized hospitalizations data for arthritis-related surgeries. J Clin Epidemiol. 2013;66(10):1128–34. doi: 10.1016/j.jclinepi.2013.04.012 23845185.
38. Peeters G, Parkinson L, Badley E, Jones M, Brown WJ, Dobson AJ, et al. Contemporaneous severity of symptoms and functioning reflected by variations in reporting doctor-diagnosed osteoarthritis. Arthritis Care Res (Hoboken). 2013;65(6):945–53. doi: 10.1002/acr.21929 23281307.
39. Jackson CA, Mishra GD. Depression and risk of stroke in midaged women: a prospective longitudinal study. Stroke. 2013;44(6):1555–60. doi: 10.1161/STROKEAHA.113.001147 23686976.
40. Alhazmi A, Stojanovski E, McEvoy M, Brown W, Garg ML. Diet quality score is a predictor of type 2 diabetes risk in women: the Australian Longitudinal Study on Women's Health. Br J Nutr. 2014;112(6):945–51. doi: 10.1017/S0007114514001688 25201303.
41. Putter H, Fiocco M, Geskus RB. Tutorial in biostatistics: competing risks and multi-state models. Stat Med. 2007;26(11):2389–430. doi: 10.1002/sim.2712 17031868.
42. Xu X, Mishra GD, Jones M. Mapping the global research landscape and knowledge gaps on multimorbidity: a bibliometric study. J Glob Health. 2017;7(1):010414. doi: 10.7189/jogh.07.010414 28685036.
Štítky
Interné lekárstvoČlánok vyšiel v časopise
PLOS Medicine
2018 Číslo 3
- Statinová intolerance
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Co dělat při intoleranci statinů?
- Pleiotropní účinky statinů na kardiovaskulární systém
- DESATORO PRE PRAX: Aktuálne odporúčanie ESPEN pre nutričný manažment u pacientov s COVID-19
Najčítanejšie v tomto čísle
- Forced anal examinations to ascertain sexual orientation and sexual behavior: An abusive and medically unsound practice
- Polycystic ovary syndrome, androgen excess, and the risk of nonalcoholic fatty liver disease in women: A longitudinal study based on a United Kingdom primary care database
- The current and potential health benefits of the National Health Service Health Check cardiovascular disease prevention programme in England: A microsimulation study
- Cardiovascular disease and multimorbidity: A call for interdisciplinary research and personalized cardiovascular care